Literature DB >> 9786069

Assessment of intracellular insulin content during all steps of human islet isolation procedure.

H Brandhorst1, D Brandhorst, M D Brendel, B J Hering, R G Bretzel.   

Abstract

This study investigated the recovery of pancreatic insulin content during human islet isolation prior to and after digestion-filtration, continuous Hanks-Ficoll gradient purification (n = 20), and 3-4 day culture at 22 degrees C (n = 6). The native insulin content varied in a wide range from 28.4 U to 360.8 U/pancreas. After digestion the initially measured average insulin content of 115.8 +/- 20.8 U/pancreas (mean +/- SEM) increased to 264.6 +/- 22.8% (p < 0.001). This increase of insulin during pancreas digestion was attributed to the asymetrical distribution of insulin within the pancreas. Sampling of insulin within the pancreatic caput seemed not to be representative for the insulin content of the complete native organ, because the ratio of insulin per gram tissue within the pancreatic cauda compared to the caput (n = 5) was 2.4 +/- 0.4 (p < 0.05). After purification total insulin recovery was 55.3 +/- 4.8% (p < 0.001). Because recovery of islet equivalent number (IEQ) (83.7 +/- 4.4%) exceeded insulin recovery, insulin/IEQ ratio decreased from 656.8 +/- 70.6 microU/IEQ before purification to 436.4 +/- 58.1 microU/IEQ (p < 0.001) after purification. After 22 degrees C culture (n = 6) recovery of insulin and IEQ was 80.1 +/- 8.1% (p < 0.05) and 92.8 +/- 3.5% (p = NS), respectively. Insulin content per IEQ decreased to 85.8 +/- 6.5% (p < 0.05). This study clearly shows that most of islet insulin is lost during purification. This seems to be caused rather by an amplified insulin release than by the loss of islets itself. This release may facilitate the separation of endocrine and exocrine tissue by gradient centrifugation, but may also accelerate islet exhaustion detrimental for long-term insulin independence.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9786069     DOI: 10.1177/096368979800700508

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.139


  21 in total

Review 1.  Islet transplant: an option for childhood diabetes?

Authors:  E Hathout; J Lakey; J Shapiro
Journal:  Arch Dis Child       Date:  2003-07       Impact factor: 3.791

2.  Neutrophilic granulocytes are the predominant cell type infiltrating pancreatic islets in contact with ABO-compatible blood.

Authors:  L Moberg; O Korsgren; B Nilsson
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

3.  A new method for incorporating functional heparin onto the surface of islets of Langerhans.

Authors:  Sanja Cabric; Torsten Eich; Javier Sanchez; Bo Nilsson; Olle Korsgren; Rolf Larsson
Journal:  Tissue Eng Part C Methods       Date:  2008-06       Impact factor: 3.056

4.  A genetically engineered human pancreatic β cell line exhibiting glucose-inducible insulin secretion.

Authors:  Philippe Ravassard; Yasmine Hazhouz; Séverine Pechberty; Emilie Bricout-Neveu; Mathieu Armanet; Paul Czernichow; Raphael Scharfmann
Journal:  J Clin Invest       Date:  2011-08-25       Impact factor: 14.808

5.  Anchoring of vascular endothelial growth factor to surface-immobilized heparin on pancreatic islets: implications for stimulating islet angiogenesis.

Authors:  Sanja Cabric; Javier Sanchez; Ulrika Johansson; Rolf Larsson; Bo Nilsson; Olle Korsgren; Peetra U Magnusson
Journal:  Tissue Eng Part A       Date:  2010-03       Impact factor: 3.845

6.  Highly purified versus filtered crude collagenase: comparable human islet isolation outcomes.

Authors:  Yong Wang; Daniel Paushter; Shusen Wang; Barbara Barbaro; Tricia Harvat; Kirstie K Danielson; Katie Kinzer; Liza Zhang; Meirigeng Qi; Jose Oberholzer
Journal:  Cell Transplant       Date:  2011-03-07       Impact factor: 4.064

7.  MiRNA-375 promotes beta pancreatic differentiation in human induced pluripotent stem (hiPS) cells.

Authors:  Reyhaneh Lahmy; Masoud Soleimani; Mohammad H Sanati; Mehrdad Behmanesh; Fatemeh Kouhkan; Naser Mobarra
Journal:  Mol Biol Rep       Date:  2014-01-29       Impact factor: 2.316

8.  Long-chain CoA esters activate human pancreatic beta-cell KATP channels: potential role in Type 2 diabetes.

Authors:  R Bränström; C A Aspinwall; S Välimäki; C-G Ostensson; A Tibell; M Eckhard; H Brandhorst; B E Corkey; P-O Berggren; O Larsson
Journal:  Diabetologia       Date:  2004-01-23       Impact factor: 10.122

9.  Influence of in vitro and in vivo oxygen modulation on β cell differentiation from human embryonic stem cells.

Authors:  Sirlene Cechin; Silvia Alvarez-Cubela; Jaime A Giraldo; Ruth D Molano; Susana Villate; Camillo Ricordi; Antonello Pileggi; Luca Inverardi; Christopher A Fraker; Juan Domínguez-Bendala
Journal:  Stem Cells Transl Med       Date:  2013-12-27       Impact factor: 6.940

10.  Anti-inflammatory thalidomide improves islet grafts survival and functions in a xenogenic environment.

Authors:  Chunguang Chen; Carina Kuehn; Reinhard G Bretzel; Thomas Linn
Journal:  PLoS One       Date:  2009-07-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.